After a simulation recently showed what happens to your body once you inject the drug, some were left horrified, but now a ...

In an age where quick fixes are often sought over true solutions, the rise of GLP-1 receptor agonists like Ozempic has sparked serious concerns about the hidden dangers of these weight-loss ...

New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, “significantly reduced” breast tissue cell growth, which is a major indicator of cancer ...

Since Spravato is FDA-approved, it’s covered by most insurance companies. IV ketamine, on the other hand, is generally not ...

A little-known artificial sweetener that’s up to 13,000 times sweeter than sugar is now used in most popular flavored e-cigarettes, a new study found.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

According to the Daily Mail, patients who take the weight-loss shots were twice as likely to suffer from a serious ...

GLP-1s are gaining interest for their impact on weight, blood sugar, and possibly mood in bipolar disorder. Here’s what ...

Biopharma financings totaled $21.38 billion through May 2025, down sharply from $62.57 billion during the same period in 2024, but roughly in line with levels seen in 2023 and 2022. Biopharma ...

A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, ...

The petition, filed by Massachusetts, New York, California, and New Jersey, aims to compel the FDA to recognize that mifepristone is safe and effective. More reproductive health news includes GLP-1 ...

The Wall Street Journal reports on the expected FDA approval of lenacapavir and what it might mean for Gilead's future in the market. Other coverage of science and research-related news is on a ...